A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice.

Qiao, Yongbo; Zhang, YaXin; Chen, Jie; Jin, Shenghui; Shan, Yaming

Qiao, Yongbo; Zhang, YaXin; Chen, Jie; Jin, Shenghui; Shan, Yaming.

Afiliación

Qiao Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012 China.
Zhang Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012 China.
Chen J; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012 China.
Jin S; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012 China.
Shan Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012 China.

Nano Res ; 15(9): 8304-8314, 2022.

Article en En | MEDLINE | ID: mdl-35911479

Palabras clave

influenza; multi-epitope; nanovaccine; universal vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nano Res Año: 2022 Tipo del documento: Article Pais de publicación: China